Multivariate^* binary logistic regression analysis of the association between smoking status and obesity stratified by gender, age and socioeconomic deprivation decile.

<p>OR odds ratio, CI confidence interval.</p><p>*adjusted for levels of physical activity and alcohol consumption, and presence of hypertension and diabetes as well as gender, age, and socioeconomic deprivation decile as appropriate.</p><p>Multivariate^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123579#t003fn002" target="_blank">*</a>} binary logistic regression analysis of the association between smoking status and obesity stratified by gender, age and socioeconomic deprivation decile.</p

Median and IQR monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

<p>Median and IQR monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

Characteristics of obese and not obese participants.

<p>N number.</p><p>*chi square test for gender, hypertension and diabetes, chi-square test for trend for remainder.</p><p>Characteristics of obese and not obese participants.</p

Forest plot of adjusted* odds ratio for obesity and lifetime consumption of cigarette smoked (pack years) among current smokers.

<p>* adjusted for levels of physical activity and alcohol consumption, and presence of hypertension and diabetes as well as gender, age, and socioeconomic deprivation decile.</p

Time series regression analyses of quarterly smoking prevalence.

<p>*Adjusted for change at March 2006 effect, and post March 2006 decay effect.</p><p>**Derived from autoregressive moving average model.</p><p>CI confidence interval; AIC Akaike Information Criterion; RMSE root mean square error.</p

Observed and expected monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

<p>Observed and expected monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

Observed and predicted monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

<p>Observed and predicted monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

Baseline characteristics of study population in relation to self-reported general health and mental health (measured by GHQ-12).

<p><i>P</i> values were determined by χ2 test.GHQ General Health Questionnaire; N number; SIMD Scottish Index of Multiple Deprivation; NM non- manual; M manual.</p

Observed and predicted quarterly smoking prevalence in Scotland (January 1999–September 2010).

<p>Observed and predicted quarterly smoking prevalence in Scotland (January 1999–September 2010).</p

Forest plot of adjusted* odds ratio for obesity and duration since quitting smoking among former smokers.

<p>* adjusted for levels of physical activity and alcohol consumption, and presence of hypertension and diabetes as well as gender, age, and socioeconomic deprivation decile.</p